About Deciphar Life Sciences Private Limited
Data last updated:
Deciphar Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Molbio Diagnostics Private Limited. It operates in the software development and support services segment of the technology and IT services sector. It was incorporated on 12 June 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74140KA2001PTC029114. Its GSTIN is 29AACCB0953E1ZX (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandrasekhar Bhaskaran Nair and Sangeetha Sriram.
Its last annual general meeting (AGM) was held on 08 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹88.94 Lakh. For the same year it recorded a net profit of ₹88.94 Lakh (net margin 100%) and EBITDA of ₹88.94 Lakh (EBITDA margin 100%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bigteclabs.com.
Company details
Contact details
Deciphar Life Sciences Private Limited's registered office is in Bangalore, Karnataka. Its website is bigteclabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2nd Floor Golden Heights 59th 'C' Cross 4th 'M' Block Rajajinag, Ar, Bangalore, Karnataka, India – 560010
- IndustryInformation Technology, Software Development & Support Services
To see the full contact details of Deciphar Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Deciphar Life Sciences Private Limited
FY 2025 filings availableDeciphar Life Sciences Private Limited reported revenue of ₹88.94 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹88.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 100% | ||||
| Net Profit Margin | 100% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Deciphar Life Sciences Private Limited, buy the company report.
Board of directors of Deciphar Life Sciences Private Limited
Deciphar Life Sciences has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrasekhar Bhaskaran Nair Also directs: Turbostart Accelerator III LLP, Molbio Diagnostics Limited, Molbio Diagnostics Limited and 5 more | Director | 10 Apr 2008 | 18 Years 6 Months | Current |
| Sangeetha Sriram Also directs: Molbio Diagnostics Limited, Molbio Diagnostics Limited, Remfuel Bioenergy Private Limited and 5 more | Director | 18 Oct 2023 | 3 Years 0 Months | Current |
Peer comparison
Deciphar Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the Information Technology industry (Application Development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Concepts Nrec India Private Limited | ₹89.49 Lakh (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Wiznet India Private Limited | ₹89.36 Lakh (FY 2023) | 1035.0% | Bangalore, Karnataka, India | |||
| Soti Kochi India Private Limited | ₹89.27 Lakh (FY 2025) | Ernakulam, Kerala, India | ||||
| Genric Solutions Private Limited | ₹89.27 Lakh (FY 2024) | -34.0% | Patiala, Punjab, India | |||
| Calibyte Private Limited | ₹89.2 Lakh (FY 2025) | 592.0% | Kurukshetra, Haryana, India | |||
| Deciphar Life Sciences Private Limitedthis company | ₹88.94 Lakh (FY 2025) | ₹88.94 Lakh | 100% | Bangalore, Karnataka, India | ||
| Cunomial Technologies Private Limited | ₹88.94 Lakh (FY 2024) | 64.0% | Raipur, Chhattisgarh, India | |||
| Rankright Infotech Private Limited | ₹88.74 Lakh (FY 2025) | 11.0% | Gandhinagar, Gujarat, India | |||
| Prem Dhillon Productions Private Limited | ₹88.58 Lakh (FY 2024) | 224.0% | Amritsar, Punjab, India | |||
| Vjyn Solutions Private Limited | ₹88.57 Lakh (FY 2024) | 3197.0% | Bengaluru, Karnataka, India | |||
| Webdirekt India Private Limited | ₹88.41 Lakh (FY 2025) | -4.0% | Pune, Maharashtra, India |
To see the full peer comparison of Deciphar Life Sciences Private Limited, buy the company report.
Auditor
Deciphar Life Sciences Private Limited is audited by T S DEVADAS & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T S DEVADAS & CO | FY 2019 | 006217S |
Shareholding
The shareholding of Deciphar Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Deciphar Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Deciphar Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deciphar Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Deciphar Life Sciences has 3 associated companies. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
GST
Deciphar Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCB0953E1ZX | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Deciphar Life Sciences Private Limited, buy the company report.
Recent activity
Deciphar Life Sciences Private Limited has 8 board changes on record since 2008: 2 appointments and 6 cessations. The latest: Sangeetha Sriram ceased to be Additional Director on 25 Sep 2024.
Frequently asked questions
Deciphar Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in software development and support services, within the information technology industry. It was incorporated on 12 June 2001 (25+ years old) and is registered under CIN U74140KA2001PTC029114.
Deciphar Life Sciences has 2 current directors:
- Chandrasekhar Bhaskaran Nair - Director
- Sangeetha Sriram - Director
The latest financial statements of Deciphar Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Deciphar Life Sciences is 29AACCB0953E1ZX, registered in Karnataka.
The CIN (Corporate Identification Number) of Deciphar Life Sciences is U74140KA2001PTC029114. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deciphar Life Sciences was incorporated on 12 June 2001, making it 25+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Deciphar Life Sciences by revenue are Concepts Nrec India Private Limited, Wiznet India Private Limited, Soti Kochi India Private Limited, Genric Solutions Private Limited, Calibyte Private Limited and 5 more, all in the Information Technology industry (Application Development).
Sangeetha Sriram ceased to be Additional Director on 25 Sep 2024. Sangeetha Sriram was appointed as Director on 18 Oct 2023. Sriram Natarajan ceased to be Additional Director on 16 Nov 2021. Deciphar Life Sciences has 8 board changes on record in total.
Deciphar Life Sciences can be reached through the website bigteclabs.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Deciphar Life Sciences is at 2nd Floor Golden Heights 59th C Cross 4th M Block Rajajinag, Ar, Bangalore, Karnataka, India – 560010.
Deciphar Life Sciences operates in the information technology industry, in the software development and support services segment.